Learn more

OPTIPHARM CO LTD

Overview
  • Total Patents
    90
  • GoodIP Patent Rank
    17,892
  • Filing trend
    ⇩ 73.0%
About

OPTIPHARM CO LTD has a total of 90 patent applications. It decreased the IP activity by 73.0%. Its first patent ever was published in 2013. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, basic materials chemistry and foods and drinks are INST TROPICAL BIOSCIENCE & BIOTECHNOLOGY CATAS, PROTEON PHARMACEUTICALS S A and PHAGELUX INC.

Patent filings per year

Chart showing OPTIPHARM CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Hyun Il 67
#2 Han Beom Ku 52
#3 Park Charl Se 49
#4 Kim Young Ju 45
#5 Yeon Young Eun 39
#6 Lee Hye Young 17
#7 Wang Hye Young 13
#8 Kim Yeun 11
#9 Shim Joo Hyun 10
#10 Choi Ki Myung 10

Latest patents

Publication Filing date Title
KR20210000659A Novel Salmonella specific bacteriophage SS1 and antibacterial composition comprising the same
KR20200078366A Novel Enterococcus specific bacteriophage EH11 and antibacterial composition comprising the same
KR20200078368A Novel Yersinia specific bacteriophage YE12 and antibacterial composition comprising the same
KR20200080162A Novel Enterococcus faecium specific bacteriophage EF44 and antibacterial composition comprising the same
KR20190132331A Novel Pseudomonas aeruginosa specific bacteriophage PA4 and antibacterial composition comprising the same
KR20190132329A Novel pathogenic Escherichia coli specific bacteriophage EC11 and antibacterial composition comprising the same
KR20190103127A Novel Vibrio specific bacteriophage VP2 and antibacterial composition comprising the same
KR102176161B1 PERV EnvC- GGTA1/CMAH/iGb3s/β4GalNT2 quadra gene knock-out and human CD46 and TBM expression transgenic pigs for xenotransplantation, and producing method thereof
KR102193477B1 Novel Salmonella specific bacteriophage ST20 and antibacterial composition comprising the same
KR20190045128A Novel Stx2e epitope protein and vaccine composition comprising the same
WO2019194543A1 Alginate microcapsules for cell encapsulation and, manufacturing method therefor
KR20190110050A Novel Virus Like Particle, Vaccine Composition for Preventing Porcine Circovirus 3 Comprising the Same, and Method for Manufacturing Thereof
KR20200081594A Novel Bacillus cereus bacteria specific bacteriophage BC13 and antibacterial composition comprising the same
KR20190079573A Novel Klebsiella genus bacteria specific bacteriophage KP12 and antibacterial composition comprising the same
KR20200080486A Novel Acinetobacter baumannii specific bacteriophage AB63 and antibacterial composition comprising the same
KR20190027761A Novel Virus Like Particle with Dual-Antigenicity, Vaccine Composition for Preventing Diseases from Canine Parvovirus and Canine distemper Virus Infection Comprising the Same, and Method for Manufacturing Thereof
KR20200008383A A method for diagnosing uterine cervical cancer by Real Time quantitative reverse-transcriptase PCR and a kit therefor
KR102058015B1 Transgenic cloned piglets defecting porcine GGTA1 gene, and expressing human CD39 and CD55 gene for xenotransplantation, and producing method thereof
KR20190112453A Transgenic cloned piglets defecting porcine GGTA1, CMAH, iGb3s and beta4GalNT2 gene for xenotransplantation, and producing method thereof
KR20190079850A Novel Salmonella specific bacteriophage SE131 and antibacterial composition comprising the same